Single-Agent Brentuximab as Bridging Therapy for Hodgkin Lymphoma Patients with Hepatic Impairment

Arjun Gupta, Jan Petrasek, Shiraj Sen, Purva Gopal, Harris V. Naina

Research output: Contribution to journalArticlepeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)e11-e14
JournalClinical Lymphoma, Myeloma and Leukemia
Issue number2
StatePublished - Feb 1 2016
Externally publishedYes


  • Anti CD-30
  • Chemotherapy
  • Hepatic impairment
  • Liver failure
  • Lymphoma

Cite this